Anavex Life Sciences Corp.
AVXLAnalyst Consensus
Price Target Trend
Rating Trend
Recent Price Targets
| Date | Firm | Analyst | Target | Price Then | Source |
|---|---|---|---|---|---|
| Dec 6, 2022 | Cantor Fitzgerald | $11.00(+29%) | $8.54 | Benzinga |
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| D. Boral Capital | maintain | Buy | Mar 31, 2026 |
| D. Boral Capital | maintain | Buy | Mar 26, 2026 |
| D. Boral Capital | maintain | Buy | Mar 23, 2026 |
| HC Wainwright & Co. | maintain | Buy | Feb 10, 2026 |
| D. Boral Capital | maintain | Buy | Feb 9, 2026 |
| D. Boral Capital | maintain | Buy | Jan 6, 2026 |
| HC Wainwright & Co. | maintain | Buy | Dec 19, 2025 |
| D. Boral Capital | maintain | Buy | Dec 19, 2025 |
| D. Boral Capital | maintain | Buy | Dec 15, 2025 |
| HC Wainwright & Co. | maintain | Buy | Nov 28, 2025 |
| D. Boral Capital | maintain | Buy | Nov 26, 2025 |
| HC Wainwright & Co. | maintain | Buy | Nov 19, 2025 |
| D. Boral Capital | maintain | Buy | Nov 14, 2025 |
| D. Boral Capital | maintain | Buy | Oct 29, 2025 |
| Jones Trading | downgrade | Buy →Hold | Oct 24, 2025 |
| HC Wainwright & Co. | maintain | Buy | Oct 7, 2025 |
| D. Boral Capital | maintain | Buy | Oct 2, 2025 |
| D. Boral Capital | maintain | Buy | Oct 1, 2025 |
| D. Boral Capital | maintain | Buy | Sep 10, 2025 |
| HC Wainwright & Co. | maintain | Buy | Sep 10, 2025 |
| D. Boral Capital | maintain | Buy | Aug 27, 2025 |
| HC Wainwright & Co. | maintain | Buy | Aug 22, 2025 |
| D. Boral Capital | maintain | Buy | Aug 13, 2025 |
| D. Boral Capital | maintain | Buy | Aug 4, 2025 |
| D. Boral Capital | maintain | Buy | Apr 7, 2025 |
Earnings History
Next report: Nov 24, 2026 · EPS est. $-0.11| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 28, 2026 | $-0.03 | $-0.08 | — | — |
| Aug 25, 2026 | $0.08 | $-0.08 | — | — |
| Feb 9, 2026 | $-0.06 | $-0.10 | — | — |
| Nov 25, 2025 | $-0.11 | $-0.13 | — | $111.6M |
| Aug 12, 2025 | $-0.16 | $-0.13 | — | $71.7M |
| May 13, 2025 | $-0.13 | $-0.16 | — | $45.5M |
| Feb 12, 2025 | $-0.14 | $-0.17 | — | — |
| Dec 23, 2024 | $-0.14 | $-0.16 | — | $45.9M |
News
New York, New York--(Newsfile Corp. - November 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - No…
New York, New York--(Newsfile Corp. - November 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation…
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
New York, New York--(Newsfile Corp. - November 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation…
Suit alleges Anavex Life Sciences Corp. failed to disclose key facts to investors from November 26, 2025 through August 28, 2026; lead plaintiff deadline is November 30, 2026 BENSALEM TOWNSHIP, Pa., Nov. 6, 2026 /PRNewswire/ -- The Law Offices of Howard G.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anavex (AVXL) To Contact Him Directly To Discuss Their Options
NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
New York, New York--(Newsfile Corp. - November 5, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Anavex and have suffered losses, you may CLICK HERE to contact us.
NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased Anavex Life Sciences securities during the Class Period you may be entitled to compensation with…
Lawsuit alleges Anavex Life Sciences Corp. made misleading statements to investors from November 26, 2025 to August 28, 2026; lead plaintiff motions are due November 30, 2026 LOS ANGELES, Nov. 5, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors who acquired the Company's securities from November 26, 2025 to August 28, 2026.
Nationally Recognized Firm Urges Anavex Investors to Explore Class Action Representation Lead Plaintiff Deadline: November 30, 2026. Investors who purchased (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026 may be eligible to recover losses.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - No…
New York, New York--(Newsfile Corp. - November 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - No…
New York, New York--(Newsfile Corp. - November 3, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Anavex and have suffered losses, you may CLICK HERE to contact us.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anavex (AVXL) To Contact Him Directly To Discuss Their Options
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
New York, New York--(Newsfile Corp. - November 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation…